Exosomes in 2026: hype and potential
Since emerging in the last 20 years, expectations for exosomes have developed into hype in some areas. What is their real potential?
Mononuclear phagocytic cells such as monocytes, macrophages and dendritic cells are at the vanguard of our immune system. Harnessing the capabilities of these cells has tremendous potential for fighting disease.
Rather than reprogramming at the level of DNA or RNA, researchers are now using PODS® sustained-release proteins to efficiently reprogram the proteome directly in-vivo.
Whether you are developing new therapies or simply delving into the mechanisms of the immune system, PODS® can help you with your quest.